Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China
- DOI
- 10.3389/fphar.2026.1840088
- Published
- 2026-08-10
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1840088,
title = {Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China},
author = {Kehui Meng and Meiyu Wu and Andong Li and Zixuan Zhang and Yangke Yi and Chaohao Shi and Xiaomin Wan and Chongqing Tan and Hao He},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1840088},
url = {https://doi.org/10.3389/fphar.2026.1840088}
}RIS
TY - JOUR TI - Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China AU - Kehui Meng AU - Meiyu Wu AU - Andong Li AU - Zixuan Zhang AU - Yangke Yi AU - Chaohao Shi AU - Xiaomin Wan AU - Chongqing Tan AU - Hao He PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1840088 UR - https://doi.org/10.3389/fphar.2026.1840088 ER -
APA
Meng, K., Wu, M., Li, A., Zhang, Z., Yi, Y., Shi, C., Wan, X., Tan, C., & He, H. (2026). Cost-effectiveness of targeted therapy versus chemotherapy for patients with advanced or metastatic gastric cancer in China. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1840088
Source records
- crossref · retrieved 2026-09-26T05:41:10.644Z